About Nymox Pharmaceutical
Nymox Pharmaceutical is a company based in Nassau (Bahamas) founded in 1989 by Paul Averback.. Nymox Pharmaceutical operates in a competitive market with competitors including Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nuage Therapeutics and Glycomantra, among others.
- Headquarter Nassau, Bahamas
- Founders Paul Averback
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Nymox Pharmaceutical Corp.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-4.49 M49.21as on Dec 31, 2024
-
EBITDA
$-4.28 M48.65as on Dec 31, 2024
-
Latest Funding Round
$9 M (USD), Post-IPO
Aug 12, 2020
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nymox Pharmaceutical
Nymox Pharmaceutical is a publicly listed company on the OTC with ticker symbol NYMXF in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Nymox Pharmaceutical
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $9.0M
-
First Round
First Round
(09 Jan 2003)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Post-IPO - Nymox Pharmaceutical | Valuation |
investors |
|
| Apr, 2018 | Amount | Post-IPO - Nymox Pharmaceutical | Valuation |
investors |
|
| Feb, 2016 | Amount | Post-IPO - Nymox Pharmaceutical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nymox Pharmaceutical
Nymox Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include USAGov. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entity focused on information and services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nymox Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nymox Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nymox Pharmaceutical Comparisons
Competitors of Nymox Pharmaceutical
Nymox Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nuage Therapeutics and Glycomantra, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Develops small molecule based drug for multiple disease treatment
|
|
| domain | founded_year | HQ Location |
Cancer therapeutics are developed using dual-targeted radionuclide therapy.
|
|
| domain | founded_year | HQ Location |
Drugs are developed for intrinsically disordered protein targets.
|
|
| domain | founded_year | HQ Location |
Translational glycobiology research on galectin-3 inhibitors is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nymox Pharmaceutical
Frequently Asked Questions about Nymox Pharmaceutical
When was Nymox Pharmaceutical founded?
Nymox Pharmaceutical was founded in 1989 and raised its 1st funding round 14 years after it was founded.
Where is Nymox Pharmaceutical located?
Nymox Pharmaceutical is headquartered in Nassau, Bahamas.
Who is the current CEO of Nymox Pharmaceutical?
Paul Averback is the current CEO of Nymox Pharmaceutical. They have also founded this company.
What does Nymox Pharmaceutical do?
Nymox engaged in the research, development, and commercialization of drugs and diagnostic products for the aging population. Its lead product nx-1207 has shown positive results in clinical trial phase 2 and follow up studies for the treatment of benign prostatic hyperplasia (BPH). Diagnostic products include NicAlert (determine smoking status) and TobacAlert (determine exposure to tobacco products). The Company also claims to have research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, morphology, and drug screening design, assays, and development.
Who are the top competitors of Nymox Pharmaceutical?
Nymox Pharmaceutical's top competitors include Radionetics, Nuage Therapeutics and Convergent Therapeutics.
Is Nymox Pharmaceutical publicly traded?
Yes, Nymox Pharmaceutical is publicly traded on OTC under the ticker symbol NYMXF.
Who are Nymox Pharmaceutical's investors?
Nymox Pharmaceutical has 1 investor. Key investors include USAGov.
What is Nymox Pharmaceutical's ticker symbol?
The ticker symbol of Nymox Pharmaceutical is NYMXF on OTC.